Empirico Inc.
Andrew Allen has a diverse work experience in various scientific roles. Andrew recently joined Empirico Inc. as a Principal Scientist in October 2022. Prior to that, they worked at Neumora as a Senior Scientist from August 2020 to October 2022. Andrew also worked at Broad Institute as a Senior Research Associate II from February 2014 to October 2022. Andrew has previous experience at Monte Rosa Therapeutics as a Scientist I from March 2020 to November 2020, Jnana Therapeutics as a Scientist I from November 2019 to February 2020, and as an Associate Scientist from October 2018 to November 2019. In addition, they worked at Dana-Farber Cancer Institute as a Lead Research Associate from May 2012 to January 2014 and at Massachusetts General Hospital as a Research Tech I-II from May 2009 to February 2012.
Andrew Allen attended Marshfield High School from 2000 to 2004. Andrew then pursued a Bachelor of Science degree in Biochemistry and Molecular Biology at UMass Amherst, graduating in 2008. Andrew continued their education at UMass Amherst and obtained a Master of Science degree in Biochemistry and Molecular Biology in 2009.
Empirico Inc.
1 followers
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritizehigh-confidence therapeutic hypotheses.